Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript

BNTX earnings call for the period ending March 31, 2024.

BNTX : 91.67 (-0.42%)
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript

BNTX earnings call for the period ending December 31, 2023.

BNTX : 91.67 (-0.42%)
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024

Analysts think these beaten-down stocks could rebound strongly in the new year.

MRK : 130.06 (-0.13%)
PFE : 28.01 (-0.60%)
BNTX : 91.67 (-0.42%)
JD : 32.20 (-0.53%)
MRNA : 117.31 (-4.39%)
BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript

BNTX earnings call for the period ending September 30, 2023.

BNTX : 91.67 (-0.42%)
3 No-Brainer Stocks to Buy for Under $100 Right Now

A couple of these stocks might not be available for under $100 for too much longer.

AZN : 77.18 (-0.55%)
BNTX : 91.67 (-0.42%)
NVS : 102.10 (+1.89%)
Is BioNTech Stock a Buy Now?

Or is it too late to get in on the company after its coronavirus-related success?

PFE : 28.01 (-0.60%)
BNTX : 91.67 (-0.42%)
Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch

USA News Group – Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully...

ONCY : 1.1700 (-5.65%)
ONC.TO : 1.59 (-5.92%)
LLY : 760.00 (-1.50%)
RHHBY : 30.9500 (+0.16%)
BNTX : 91.67 (-0.42%)
ME : 0.4975 (-2.45%)
Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END

LLY : 760.00 (-1.50%)
ONCY : 1.1700 (-5.65%)
ONC.TO : 1.59 (-5.92%)
RHHBY : 30.9500 (+0.16%)
BNTX : 91.67 (-0.42%)
ME : 0.4975 (-2.45%)
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?

The venerable pharmaceutical companies' shares have slumped this year.

BMY : 44.94 (+0.45%)
SGEN : 228.74 (-0.07%)
REGN : 973.80 (+0.60%)
BNTX : 91.67 (-0.42%)
PFE : 28.01 (-0.60%)
RHHBY : 30.9500 (+0.16%)
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research

/PRNewswire/ -- USA News Group - According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic...

ONC.TO : 1.59 (-5.92%)
BNTX : 91.67 (-0.42%)
ONCY : 1.1700 (-5.65%)
SGEN : 228.74 (-0.07%)
MYGN : 25.47 (+0.87%)
ILMN : 110.53 (-0.74%)

Barchart Exclusives

1 Overlooked AI Stock for Growth and Passive Income
This overlooked tech company posted strong results and guidance leading to an upgrade from analysts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar